Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

The outbreak of the novel coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-19 was first reported in late December 2019. Many patients with psoriasis on biologic therapy have asked their medical providers about the effect of biologics on COVID-19. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Brownstone, Nicholas D., Thibodeaux, Quinn G., Reddy, Vidhatha D., Myers, Bridget A., Chan, Stephanie Y., Bhutani, Tina, Liao, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255969/
https://www.ncbi.nlm.nih.gov/pubmed/32468230
http://dx.doi.org/10.1007/s13555-020-00394-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255969/
https://www.ncbi.nlm.nih.gov/pubmed/32468230
http://dx.doi.org/10.1007/s13555-020-00394-8

Ejemplares similares